Pheton Holdings (PTHL) Company Sales Revenue

Corporate emblem and logo of Pheton (PTHL)

Pheton Holdings Ltd is developing joint brachytherapy methods with Chinese clinics to combat cancer. The company's sales figures reflect the dynamics of this process, with the current level standing at 0.00. Simultaneously, the firm is implementing ESG standards by reducing chemical waste and ensuring the ethics of its research. Business stability is supported by a robust IT infrastructure of server nodes, which completely eliminates the risk of technical failures.

PTHL (ftzy.com.cn) Revenue and Sales Volume history from 09/06/2024 to 01/16/2026

Analytical breakdowns for Pheton Holdings Limited (PTHL)

- market price and analyst price targets:
- market capitalization details:
Comprehensive company analysis:PTHL (Pheton Holdings Limited)
Original product of Pheton Holdings

Pheton Holdings Ltd sales reflect real market demand through daily product volume, eliminating accounting reporting time lags. By analyzing the company's sales figures, an investor assesses actual revenue dynamics and business model resilience in real time. This metric aggregates all cash inflows from core operations over a 24-hour period. For Pheton Holdings Ltd (PTHL), such stability is confirmed by the critical importance of oncotherapy, which remains independent of market cycles.

Analysis of competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Revenue and Sales Volume|SXTC (China SXT Pharmaceuticals, Inc.) - Company Total Sales|Company Revenue eupraxiapharma.com (EPRX)|Company Total Sales BHST|Company Revenue eXoZymes EXOZ|Company Sales Revenue ORMP|ENTX - Company Revenue|HYFT: Company Revenue|ABVC BioPharma, Inc (ABVC) - Company Revenue|Cumberland Pharma - Company Sales Revenue|QNTM (Quantum BioPharma Corp) - Revenue and Sales Volume|FibroGen, Inc. - Company Annual Revenue|Revenue and Sales Volume TELO|Company Gross Revenue Rani Therapeutics Holdings, Inc.|Company Revenue Synergy CHC Corp. SNYR|Revenue and Sales Volume rallybio.com RLYB|Lexaria Bioscience Corp. - Revenue and Sales Volume|PULM: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP